I'll agree, today's action shouldn't change anything long
I'll agree, today's action shouldn't change anything long term but it sure doesn't feel like news is imminent.
They keep stating on the other board that Uplisting in Q1 is 100% sure thing and Doc stated that. Can we all agree he Has Not stated this?
What he has said is "all on track" and replied Nasdaq when asked about Q1. The latter could've simply been short for "I'm trying for Nasdaq"
I'm not bashing the stock but I don't think it needs pumped either. Our share price will take care of itself once (if ever) Doc releases the news. I didn't buy unvc to flip like some of them or sell at 10 or 20 cents. I just don't think people should be mislead by others who supposedly communicate with Doc and say things are 100%.
Just to be clear I don't think you are a pumper. You had to come over here to say and question what you wanted to about Doc. You had many questions and through your digging I assume got them answered the best you could.
Again if anyone can post where he said "we will uplist " or "100%" please post.
4
1
Scroll down for more posts ▼
Top 10 Most Recent News Articles
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
Top 5 Most Recently Viewed Articles
Financial Overview of Provident Financial Holdings Provident Financial Holdings, Inc. (NASDAQ: PROV) has released its fiscal results, reflecting a journey through various economic challenges. Net income reported for the quarter ending June 30, 2025, reached $1.63 million, illustrating a decrease from the previous period and shedding light on the company’s adaptability...
Continue Reading
Nanobiotix Announces Significant Findings in Pancreatic Cancer Treatment Nanobiotix has recently revealed the full results of a groundbreaking Phase 1 study focusing on JNJ-1900 (NBTXR3) and its effectiveness in treating pancreatic cancer. This study, conducted with a group of 22 patients suffering from locally advanced or borderline resectable pancreatic cancer, aims to...
Continue Reading
EverQuote Achieves Remarkable Revenue Growth in Q2 EverQuote, Inc. (Nasdaq: EVER), a prominent name in the online insurance marketplace, has announced its financial performance for the second quarter, showcasing an impressive revenue growth of 34% year-over-year, reaching $156.6 million. This significant increase reflects the effectiveness of our business strategy and the...
Continue Reading
The New Era of Medicaid Provider Enrollment In an exciting development for the healthcare sector, Noridian Healthcare Solutions, LLC, in collaboration with HHS Technology Group, LLC (HTG), is set to significantly streamline the Medicaid provider enrollment process. This partnership aims to enhance the experience of both healthcare providers and patients, ensuring better...
Continue Reading
Seamless Air Alliance Launches Innovative Wi-Fi Tracking Venture Seamless Air Alliance (SAA) has stepped into a transformative phase with the announcement of a groundbreaking initiative aimed at measuring inflight Wi-Fi performance. As a leading player in developing global standards for inflight connectivity, SAA is on a mission to elevate the travel experience by...
Continue Reading